Stock Watch: Will Static Pricing And Rising Inflation Compress Pharmaceutical Margins?
Inflation Should Impact At Least Generic Pharmaceutical Margins First
Generic pharmaceutical margins are notoriously thin while pricing is limited by intense competition. What happens to margins when raw material and energy pressures rise?
You may also be interested in...
Novartis’s use of the phrase “incident population” should have sent shock waves through companies developing gene and cellular therapies. Instead, like the stock price reaction to its lower revenues, the response was demure.
Industry body Medicines for Europe is calling for pharmaceutical manufacturers to be excluded from energy restriction policies for winter 2022 in an open letter to EU governance bodies. It warns that inflation and energy costs threaten European drug makers with closures and rationing.
Fewer rebate penalties than lawmakers expected may be assessed in the coming year because of the current high rate of general inflation.